IA
SCMP

Icon Advisers’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Icon Advisers’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-33,721
Closed -$371K – 438
2017
Q1 		$371K Sell
33,721
-49,000
-59% -$569K 0.03% 360
2016
Q4 		$1.12M Sell
82,721
-6,200
-7% -$86.5K 0.08% 270
2016
Q3 		$1.09M Buy
88,921
+68,000
+325% +$801K 0.07% 290
2016
Q2 		$230K Hold
20,921
– – 0.02% 364
2016
Q1 		$229K Sell
20,921
-39,371
-65% -$497K 0.02% 327
2015
Q4 		$1.04M Buy
60,292
+40,792
+209% +$731K 0.07% 229
2015
Q3 		$387K Sell
19,500
-7,812
-29% -$179K 0.03% 311
2015
Q2 		$448K Buy
+27,312
New +$474K 0.03% 305
2014
Q2 		– Sell
-61,000
Closed -$436K – 385
2014
Q1 		$436K Buy
+61,000
New +$522K 0.03% 254

Other funds holding SCMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Icon Advisers's SCMP Position: Q2 2017 in Review

Icon Advisers sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q2 2017, closing a stake of 33,721 shares — an estimated $371K sold.

Icon Advisers first reported a position in SCMP in Q1 2014 and held it in 9 quarters. The position peaked at $1.12M in Q4 2016. 167 funds tracked by Wall St. Rank hold SCMP as of Q2 2017.

  • Icon Advisers reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • Icon Advisers sold 33,721 Sucampo Pharmaceuticals, Inc. shares in Q2 2017, an estimated $371K.
  • Icon Advisers first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2014 and held it in 9 quarters.
  • Icon Advisers's Sucampo Pharmaceuticals, Inc. position peaked at $1.12M in Q4 2016.
  • 167 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q2 2017.

Based on Icon Advisers's 13F filing for Q2 2017, filed 10 Aug 2017.